PhotoThera, based in Carlsbad, California, has developed a proprietary,
non-invasive, light-based therapy, called NeuroThera™, for the
treatment of ischemic stroke. Ischemic stroke occurs when a vessel
supplying blood to the brain becomes blocked by a clot or a buildup of
plaque. Estimates show that, in the United States, there are more than
500,000 ischemic strokes annually, and that stroke is the leading cause
of serious long-term disability. In an initial clinical trial, the
NeuroThera device has demonstrated efficacy up to 24 hours after the
onset of stroke. In May 2006, Warburg Pincus participated in a $30.5
million round of Series C venture funding in the company, alongside
Delphi Ventures, DeNovo Ventures, Hamilton BioVentures, The Vertical
Group, and Solstice Capital to fund the Company’s planned U.S. pivotal
clinical trial.
Back
to Previous Page